Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

E-ISSN： 1097-0142|120|4|548-554

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.4, 2014-02, pp. : 548-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis and optimization of interactions between peptides mimicking the GD2 ganglioside and the monoclonal antibody 14G2a

International Journal of Molecular Medicine, Vol. 28, Iss. 1, 2011-01 ,pp. : 47-57

Spandidos Publications

Access to resources Recommend Favorite

Therapeutic plasma exchange for kidney transplantation: the problem of antibody‐mediated rejection

TRANSFUSION, Vol. 55, Iss. 4, 2015-04 ,pp. : 696-699

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 118-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐huCD20 Antibody Therapy for Antibody‐Mediated Rejection of Renal Allografts in a Mouse Model

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1192-1204

John Wiley & Sons Inc

Access to resources Recommend Favorite

bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody‐mediated immune activation and repression

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 268, Iss. 1, 2015-11 ,pp. : 52-65

John Wiley & Sons Inc

Access to resources Recommend Favorite